Mark J. Ehlert

Mark brings over 40 years of Quality and Regulatory expertise in the fields of Medical Devices and Drug development. He currently serves as President of 315 Ventures, Ltd., a small company devoted to Bioscience and Medical Device companies involved in remediation and improvement activities, start-up operations and due diligence activities associated with Mergers and Acquisitions. Mr. Ehlert has been instrumental in the formation of the Innovation Shore Angels, an angel investment and advisory group in the Upper Peninsula of Michigan.